Full text is available at the source.
Abstract
Metformin may influence important hallmarks of aging beyond lowering blood glucose levels.
- Metformin activates AMPK, triggering a series of molecular events.
- These events include the inhibition of mTOR, increased production of energy-producing structures in cells, and enhanced cellular recycling processes.
- Metformin alters gut microbiota by promoting bacteria that produce short-chain fatty acids.
- This alteration may lower inflammation, improve metabolic health, and maintain stability in gene expression.
- The TAME trial aims to assess whether metformin can slow down multiple age-related diseases.
Simplified
Longevity & Aging